Correction: A randomized, open-label, parallel, multi-center Phase IV study to compare the efficacy and safety of atorvastatin 10 and 20 mg in high-risk Asian patients with hypercholesterolemia.

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0245481.].